Nucleic Acid DDS: Drug Delivery Technology Realizing Gene-Targeted Therapy ~Analysis of R&D Trends in Patents, Papers, and Grants~
NQ Score
77/100
N1 Content Completeness
8
AI Summary (NQ-processed)
Astamuse Co., Ltd. has released a report analyzing research and development trends in nucleic acid DDS (Drug Delivery System), a technology realizing gene-targeted therapy, based on patents, papers, and grants. The report details challenges in intracellular delivery of nucleic acid drugs, the evolution of next-generation technologies (LNP, active targeting, etc.), and annual trends in related patents.